Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS
Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms
Fingolimod granted FDA Breakthrough Therapy designation...
Fingolimod granted FDA Breakthrough Therapy designation...
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2147 Views
-
Last post by frodo
-
- 0 Replies
- 9807 Views
-
Last post by NHE
-
- 2 Replies
- 1616 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1792 Views
-
Last post by Petr75
-
- 0 Replies
- 1207 Views
-
Last post by NHE
-
- 2 Replies
- 1853 Views
-
Last post by frodo
-
- 0 Replies
- 10662 Views
-
Last post by NHE
-
- 0 Replies
- 2485 Views
-
Last post by frodo
-
- 0 Replies
- 2583 Views
-
Last post by NHE